|
C14ORF126 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.73194791841524E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.63264973657351E-13 |
| Normal-vs-Stage2 |
9.027600E-02 |
| Normal-vs-Stage3 |
3.20188320301895E-13 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.784800E-03 |
| Stage1-vs-Stage3 |
1.294610E-01 |
| Stage1-vs-Stage4 |
8.94750051827486E-10 |
| Stage2-vs-Stage3 |
4.768000E-04 |
| Stage2-vs-Stage4 |
7.8945999959501E-08 |
| Stage3-vs-Stage4 |
1.063320E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65778502037028E-12 |
| Normal-vs-AfricanAmerican |
3.50359999901073E-08 |
| Normal-vs-Asian |
4.88498130835069E-15 |
| Caucasian-vs-AfricanAmerican |
6.803800E-01 |
| Caucasian-vs-Asian |
1.210010E-01 |
| AfricanAmerican-vs-Asian |
7.015600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.09500186695755E-11 |
| Normal-vs-Female |
1.81943349275571E-12 |
| Male-vs-Female |
6.605200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.67377223192489E-12 |
| Normal-vs-Age(41-60Yrs) |
2.3063773113563E-12 |
| Normal-vs-Age(61-80Yrs) |
5.89030002551283E-09 |
| Normal-vs-Age(81-100Yrs) |
4.953600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.390200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.394600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.212800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.912400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.180400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.806600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.162860E-04 |
| Classical-VS-Follicular |
1.887499999631E-07 |
| Classical-VS-Other |
9.847400E-01 |
| Classical-VS-Normal |
1.63624669369256E-12 |
| Tall-VS-Follicular |
7.94310173191093E-11 |
| Tall-VS-Other |
3.679000E-01 |
| Tall-VS-Normal |
1.11022302462516E-16 |
| Follicular-VS-Other |
1.533780E-01 |
| Follicular-VS-Normal |
2.480900E-03 |
| Other-VS-Normal |
7.104000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.84460002827791E-10 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
9.0088000004318E-07 |
|
|
